Cite this: Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants - Medscape - Aug 01, 2003. The DA of a very preterm infant has minimal constriction ...

Among other elements of the bill are that it authorises the Federal Trade Commission (FTC) to enforce the prohibition and imposes limits on patent litigation involving biological products.

Background: Patent ductus arteriosus (PDA) is a dramatically harmful disease in the neonatal period, in particular common in preterm infants, and our study was to determine related factors of PDA in ...

Objective To compare the efficacy and safety of oral versus intravenous ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in less mature preterm infants. Design Prospective, ...

AIMS To identify the patent ductus arteriosus (PDA) shunt flow pattern using Doppler echocardiography; and to assess whether it could be used to predict the development of clinically significant PDA.